Literature DB >> 20444903

Optimal replication of human cytomegalovirus correlates with endocytosis of glycoprotein gpUL132.

Barbara Kropff1, Yvonne Koedel, William Britt, Michael Mach.   

Abstract

Envelopment of a herpesvirus particle is a complex process of which much is still to be learned. We previously identified the glycoprotein gpUL132 of human cytomegalovirus (HCMV) as an envelope component of the virion. In its carboxy-terminal portion, gpUL132 contains at least four motifs for sorting of transmembrane proteins to endosomes; among them are one dileucine-based signal and three tyrosine-based signals of the YXXØ and NPXY (where X stands for any amino acid, and Ø stands for any bulky hydrophobic amino acid) types. To investigate the role of each of these trafficking signals in intracellular localization and viral replication, we constructed a panel of expression plasmids and recombinant viruses in which the signals were rendered nonfunctional by mutagenesis. In transfected cells wild-type gpUL132 was mainly associated with the trans-Golgi network. Consecutive mutation of the trafficking signals resulted in increasing fractions of the protein localized at the cell surface, with gpUL132 mutated in all four trafficking motifs predominantly associated with the plasma membrane. Concomitant with increased surface expression, endocytosis of mutant gpUL132 was reduced, with a gpUL132 expressing all four motifs in mutated form being almost completely impaired in endocytosis. The replication of recombinant viruses harboring mutations in single trafficking motifs was comparable to replication of wild-type virus. In contrast, viruses containing mutations in three or four of the trafficking signals showed pronounced deficits in replication with a reduction of approximately 100-fold. Moreover, recombinant viruses expressing gpUL132 with three or four trafficking motifs mutated failed to incorporate the mutant protein into the virus particle. These results demonstrate a role of endocytosis of an HCMV envelope glycoprotein for incorporation into the virion and optimal virus replication.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20444903      PMCID: PMC2898235          DOI: 10.1128/JVI.01644-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  58 in total

Review 1.  The role of virion membrane protein endocytosis in the herpesvirus life cycle.

Authors:  A D Brideau; L W Enquist; R S Tirabassi
Journal:  J Clin Virol       Date:  2000-08       Impact factor: 3.168

Review 2.  Herpesvirus assembly and egress.

Authors:  Thomas C Mettenleiter
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

3.  Truncation of herpes simplex virus type 2 glycoprotein B increases its cell surface expression and activity in cell-cell fusion, but these properties are unrelated.

Authors:  Zhenghong Fan; Michael L Grantham; M Shane Smith; Eric S Anderson; James A Cardelli; Martin I Muggeridge
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

4.  Role of the varicella-zoster virus gB cytoplasmic domain in gB transport and viral egress.

Authors:  Thomas C Heineman; Susan L Hall
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

5.  Accumulation of virion tegument and envelope proteins in a stable cytoplasmic compartment during human cytomegalovirus replication: characterization of a potential site of virus assembly.

Authors:  V Sanchez; K D Greis; E Sztul; W J Britt
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

6.  Retrieval of human cytomegalovirus glycoprotein B from cell surface is not required for virus envelopment in astrocytoma cells.

Authors:  Michael A Jarvis; Kenneth N Fish; Cecilia Söderberg-Naucler; Daniel N Streblow; Heather L Meyers; Gary Thomas; Jay A Nelson
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

7.  Disabled-2 exhibits the properties of a cargo-selective endocytic clathrin adaptor.

Authors:  Sanjay K Mishra; Peter A Keyel; Matthew J Hawryluk; Nicole R Agostinelli; Simon C Watkins; Linton M Traub
Journal:  EMBO J       Date:  2002-09-16       Impact factor: 11.598

8.  Physical interaction between envelope glycoproteins E and M of pseudorabies virus and the major tegument protein UL49.

Authors:  Walter Fuchs; Barbara G Klupp; Harald Granzow; Christoph Hengartner; Alexandra Brack; Alice Mundt; Lynn W Enquist; Thomas C Mettenleiter
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

9.  A tyrosine-based motif in the cytoplasmic tail of pseudorabies virus glycoprotein B is important for both antibody-induced internalization of viral glycoproteins and efficient cell-to-cell spread.

Authors:  Herman W Favoreel; Geert Van Minnebruggen; Hans J Nauwynck; Lynn W Enquist; Maurice B Pensaert
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

10.  Crystal structure of the HSV-1 Fc receptor bound to Fc reveals a mechanism for antibody bipolar bridging.

Authors:  Elizabeth R Sprague; Chu Wang; David Baker; Pamela J Bjorkman
Journal:  PLoS Biol       Date:  2006-05-02       Impact factor: 8.029

View more
  9 in total

1.  Interaction of Human Cytomegalovirus Tegument Proteins ppUL35 and ppUL35A with Sorting Nexin 5 Regulates Glycoprotein B (gpUL55) Localization.

Authors:  Gregor Maschkowitz; Sabine Gärtner; Heike Hofmann-Winkler; Helmut Fickenscher; Michael Winkler
Journal:  J Virol       Date:  2018-04-13       Impact factor: 5.103

2.  A Tyrosine-Based Trafficking Motif of the Tegument Protein pUL71 Is Crucial for Human Cytomegalovirus Secondary Envelopment.

Authors:  Andrea N Dietz; Clarissa Villinger; Stefan Becker; Manfred Frick; Jens von Einem
Journal:  J Virol       Date:  2017-12-14       Impact factor: 5.103

3.  Regulation of Human Cytomegalovirus Secondary Envelopment by a C-Terminal Tetralysine Motif in pUL71.

Authors:  Clarissa Read; Martin Schauflinger; Dimitri Nikolaenko; Paul Walther; Jens von Einem
Journal:  J Virol       Date:  2019-06-14       Impact factor: 5.103

4.  Human Cytomegalovirus Hijacks WD Repeat Domain 11 for Virion Assembly Compartment Formation and Virion Morphogenesis.

Authors:  Bo Yang; YongXuan Yao; Han Cheng; William J Britt; Sitang Gong; Min-Hua Luo; Xian-Zhang Wang; Yue-Peng Zhou; Sheng-Nan Huang; Xuehui Ma; Hong Yang; Jinpeng Wu; Xuan Jiang; Shuang Cheng; Jin-Yan Sun; Wen-Bo Zeng; Jason Chen; Fu-Kun Zhang; Hong-Jie Shen; Jian-Yang Gu; Michael A McVoy
Journal:  J Virol       Date:  2022-01-12       Impact factor: 6.549

5.  B cell repertoire analysis identifies new antigenic domains on glycoprotein B of human cytomegalovirus which are target of neutralizing antibodies.

Authors:  Sonja Pötzsch; Nadja Spindler; Anna-Katharina Wiegers; Tanja Fisch; Pia Rücker; Heinrich Sticht; Nina Grieb; Tina Baroti; Florian Weisel; Thomas Stamminger; Luis Martin-Parras; Michael Mach; Thomas H Winkler
Journal:  PLoS Pathog       Date:  2011-08-11       Impact factor: 6.823

6.  Quantitative temporal viromics: an approach to investigate host-pathogen interaction.

Authors:  Michael P Weekes; Peter Tomasec; Edward L Huttlin; Ceri A Fielding; David Nusinow; Richard J Stanton; Eddie C Y Wang; Rebecca Aicheler; Isa Murrell; Gavin W G Wilkinson; Paul J Lehner; Steven P Gygi
Journal:  Cell       Date:  2014-06-05       Impact factor: 41.582

7.  Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus.

Authors:  Anna Bootz; Astrid Karbach; Johannes Spindler; Barbara Kropff; Nina Reuter; Heinrich Sticht; Thomas H Winkler; William J Britt; Michael Mach
Journal:  PLoS Pathog       Date:  2017-08-30       Impact factor: 6.823

8.  Qualitative Differences in Capsidless L-Particles Released as a By-Product of Bovine Herpesvirus 1 and Herpes Simplex Virus 1 Infections.

Authors:  Tiffany Russell; Ben Bleasdale; Michael Hollinshead; Gillian Elliott
Journal:  J Virol       Date:  2018-10-29       Impact factor: 5.103

9.  Human Cytomegalovirus Envelope Protein gpUL132 Regulates Infectious Virus Production through Formation of the Viral Assembly Compartment.

Authors:  Hui Wu; Barbara Kropff; Michael Mach; William J Britt
Journal:  mBio       Date:  2020-09-29       Impact factor: 7.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.